Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are two major infectious diseases causing serious public health problems. The main route of transmission of both these diseases are through respiratory droplets and they primarily target the lungs.
Breast cancer is the most common form of cancer among women in Malaysia. According to the Statistics report made by Global Cancer Observatory in 2020, Breast cancer has been ranked first in the incidence and prevalence rate of cancer among Malaysians.
Autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease and Crohn’s disease are commonly treated with biologics to slow progression of the disease. Unfortunately, biologics such as TNF-α inhibitors can also increase the likelihood that patients carrying latent TB infection will progress to active TB
Lung cancer is the leading cause of cancer death among both men and women, accounting for about one-quarter of all cancer deaths combined. Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is a substance that blocks the activity of a protein called epidermal growth factor receptor (EGFR), which is found on the surface of some normal cells and is involved in cell growth.
